Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

BCG-vaccinated cattle less infectious to other cattle, study finds
The UK government is currently conducting its own research into a deployable vaccine for cattle.
Study in Ethiopia suggests elimination of bovine TB in country is possible.

TB-infected cattle that have previously been given the Bacillus Calmette-Guérin (BCG) vaccine are less infectious to other cattle, a new study has found.
 
The research, led by the University of Cambridge and Penn State University, found that the BCG vaccine reduced TB transmission between cattle by 74 per cent per cent.

It is the first time this indirect benefit of the vaccine has been measured by scientists.

Conducted in Ethiopia, the study made use of livestock census and movement data to develop a transmission model.

Ethopia has the largest cattle population in Africa, but currently lacks a control programme for bovine TB. Intensive testing and slaughtering infected animals, as carried out in countries such as the UK, is considered to be unfeasible to implement in Ethiopia and other similar countries due to social and economic reasons.

Professor Conlan, associate professor of epidemiology at the University of Cambridge's Department of Veterinary Medicine and one of the authors of the study, said: "Results of the model suggest that vaccinating calves within the dairy sector of Ethiopia could reduce the reproduction number of the bacterium -- the R0 -- to below 1, arresting the projected increase in the burden of disease and putting herds on a pathway towards elimination of TB.”

The UK government is currently conducting its own research into creating a deployable vaccine and new DIVA skin test for bovine TB. Currently, the UK does not use the BCG vaccine because it can lead to vaccinated cattle giving false positive test results.

James Wood, Alborada professor of equine and farm animal science at the University of Cambridge's Department of Veterinary Medicine, said: "For over twenty years the UK government has pinned hopes on cattle vaccination for bovine tuberculosis as a solution to reduce the disease and the consequent costs of the controls.

“These results provide important support for the epidemiological benefit that cattle vaccination could have to reduce rates of transmission to and within herds."

The study has been published in the journal Science.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Survey launched to investigate EHV

News Story 1
 Zoetis has launched a new survey to identify management techniques for Equine Herpes Virus (EHV).

EHV is a contagious, airborne virus that can cause respiratory problems and severe diseases in horses and ponies. It spreads among horses over short distances, direct contact and through shared equipment.

The survey will explore current knowledge and management practices with EHV in the UK. It is quick to complete and participants could win one of 10 equine first aid kits.

Complete the survey here

Click here for more...
News Shorts
WSAVA launches pet travel guidance factsheet

A new pet travel guidance factsheet for veterinary professionals and caregivers has been developed by the WSAVA in collaboration with the World Veterinary Association.

The Dog and Cat Welfare During Transport factsheet provides step-by-step guidance for all stages of a journey, from pre-travel checklists to post-travel care.

Brachycephalic breeds or animals prone to travel-related anxiety are given special focus in this guide, which also provides links to IATA container regulation and WSAVA vaccination guidelines.